−1.70 NOK
−48.33 M NOK
0.00 NOK
34.26 M
About EXACT THERAPEUTICS AS
Sector
Industry
CEO
Per Walday
Website
Headquarters
Oslo
Founded
2012
ISIN
NO0010852213
FIGI
BBG00W0H5K01
EXACT Therapeutics AS is a clinical stage biopharmaceutical company, which engages in the research and development of novel platform for ultrasound mediated therapeutic amplification. It focuses on Acoustic Cluster Therapy (ACT) platform, an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology, infectious diseases, and neurological conditions. The company was founded by Svein Kvale, Per Christian Sontum, and Andrew John Healey in 2012 and is headquartered in Oslo, Norway.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EXTX is 3.72 NOK — it has increased by 3.91% in the past 24 hours. Watch EXACT THERAPEUTICS AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange EXACT THERAPEUTICS AS stocks are traded under the ticker EXTX.
EXTX stock has risen by 1.09% compared to the previous week, the month change is a −35.86% fall, over the last year EXACT THERAPEUTICS AS has showed a −66.18% decrease.
EXTX reached its all-time high on Jul 15, 2020 with the price of 53.60 NOK, and its all-time low was 3.34 NOK and was reached on Dec 18, 2024. View more price dynamics on EXTX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EXTX stock is 9.36% volatile and has beta coefficient of 0.14. Track EXACT THERAPEUTICS AS stock price on the chart and check out the list of the most volatile stocks — is EXACT THERAPEUTICS AS there?
Today EXACT THERAPEUTICS AS has the market capitalization of 155.14 M, it has increased by 21.06% over the last week.
Yes, you can track EXACT THERAPEUTICS AS financials in yearly and quarterly reports right on TradingView.
EXTX net income for the last half-year is −29.30 M NOK, while the previous report showed −25.53 M NOK of net income which accounts for −14.76% change. Track more EXACT THERAPEUTICS AS financial stats to get the full picture.
No, EXTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EXTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXACT THERAPEUTICS AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXACT THERAPEUTICS AS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXACT THERAPEUTICS AS stock shows the strong sell signal. See more of EXACT THERAPEUTICS AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.